Tradestie Institutional Equity Comparison Engine

GRAL vs TWST โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

TWST Overall Edge

TWST Captures Institutional Edge (3โ€“1 Pillars ยท 4โ€“6 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Twist Bioscience Corporation Common Stock (TWST) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while GRAL counters with relative strength in Valuation. Fundamentally, GRAL trades at 1.1x Forward P/E with -332.0% operating margin (+3.7% YoY revenue) versus TWST at N/M Forward P/E and -28.8% operating margin (+27.9% YoY). In options structure, GRAL sits in BREAKDOWN (53rd %ile IV; Dealer Gamma Walls on Pro) against TWST sits in CONSOLIDATION (19th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner GRAL
GRAL 1.1x vs TWST N/M Fwd P/E
Growth & Margin Winner TWST
Op Margin -332.0% vs -28.8% ยท YoY +3.7% vs +27.9%
Momentum & Technical Winner TWST
1Y +24.6% vs +251.3% ยท 52W Pos 51% vs 42%
Options & Structure Winner TWST
BREAKDOWN (53rd %ile IV) vs CONSOLIDATION (19th %ile IV)
GRAL NASDAQ
GRAIL, Inc. Common Stock
Services-Medical Laboratories
$105.60
-8.88% 1D
Market Cap $5.2B
1M Return -10.36%
1Y Return +24.57%
Forward P/E 1.1x
Unified AI Score
54.5 / 100 HOLD
Tech 35.0 Fund 49.0 Flow 57.0 Mom 60.0
TWST NASDAQ
Twist Bioscience Corporation Common Stock
Biological Products, (No Disgnostic Substances)
$105.04
-5.88% 1D
Market Cap $7.4B
1M Return -20.87%
1Y Return +251.3%
Forward P/E N/M
Unified AI Score
51.7 / 100 HOLD
Tech 40.0 Fund 56.0 Flow 68.0 Mom 64.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: GRAL +24.57% TWST +251.3% Spread: +224.38 pp (TWST Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period GRAL Revenue TWST Revenue GRAL Op. Margin TWST Op. Margin Margin Edge
FY2018 N/A $30M N/A -277.5% TWST
FY2019 N/A $50M N/A -200.1% TWST
FY2020 N/A $90M N/A -155.5% TWST
FY2021 N/A $130M N/A -115.4% TWST
FY2022 N/A $200M N/A -115.3% TWST
FY2023 $90M $250M -1627.6% -88.6% TWST
FY2024 $130M $310M -1743.0% -70.6% TWST
FY2025 $150M $380M -382.0% -36.2% TWST

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: GRAL (6) vs TWST (4)
Institutional Metric GRAL TWST Criterion Row Winner
Market Capitalization Scale $5.2B $7.4B Larger Scale TWST
Trailing P/E Ratio Valuation 1.1x N/M Lower Multiple GRAL
Forward P/E Ratio Valuation 1.1x N/M Lower Multiple GRAL
Revenue Growth (YoY) Growth +3.7% +27.9% Higher Growth TWST
Operating Margin (TTM) Profitability -332.0% -28.8% Higher Margin TWST
Net Profit Margin Profitability -243.8% -28.3% Higher Margin TWST
Return on Equity (ROE) Capital Efficiency -17.3% -19.1% Higher ROE GRAL
52-Week Range Position Momentum 51% ($42โ€“$166) 42% ($23โ€“$220) Stronger Trend GRAL
Beta / 30D Volatility Risk Regime 3.09ฮฒ ยท 99% Vol 3.13ฮฒ ยท 126% Vol Lower Realized Risk GRAL
Unified Institutional Score Composite Signal 54.5 / 100 (HOLD) 51.7 / 100 (HOLD) Higher Composite GRAL

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full GRAL vs TWST Buy Guide
GRAL BREAKDOWN
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 53rd %ile
IV Regime Balanced (25thโ€“60th %ile)
Live GRAL Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
TWST CONSOLIDATION
69d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 19th %ile
IV Regime Compressed (<25th %ile)
Live TWST Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither GRAL nor TWST registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.